Yoni Freedhoff, MD, reviews the new book 'Food Intelligence,' which details the impact of food on nutrition, biochemistry, metabolism, and health.
Many patients inquire about the risk of suicidal ideation with GLP-1s, writes Yoni Freedhoff, MD. Rather than increasing the risk, he has found they actually decrease it.
Cancer prevention guidelines and studies fail to mention weight loss medications and surgeries, and their ability to decrease risk. Is this another form of weight bias?
Recent research suggests that patients prescribed GLP-1s don’t fill their prescriptions or stop taking them. Yoni Freedhoff, MD, discusses the obstacles to patient adherence.
Recent reports that the decrease in obesity rates is due to increased prescribing of antiobesity medications are unfounded. Yoni Freedhoff, MD, explains why it’s just not possible.
Advertising sugary cereals and salty snacks to kids is rampant on social media. Do bans on such marketing create a decrease in the demand for these processed foods?
Two prominent medical associations recommend treating people with obesity like actual people. Yoni Freedhoff, MD, explains why this is another form of bias.
Nestlé recently announced they would sell food targeted for customers on anti-obesity medications. Yoni Freedhoff, MD, explains why this move should be celebrated.
New draft recommendations focus on lecturing children with obesity about diet while ignoring medications or surgery. Dr Yoni Freedhoff says this is another form of weight bias.